Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Ambulatory Blood Pressure Monitoring (ABPM) Extension Study of Oral Testosterone Undecanoate in Hypogonadal Men

ClinicalTrials.gov ID: NCT04467697

Public ClinicalTrials.gov record NCT04467697. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 2:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 6 Month, Open Label, Ambulatory Blood Pressure Monitoring (ABPM) Extension Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this six-month treatment study is * to assess feasibility of a lower starting dose of SOV2012-F1 (daily dose of 400 mg \[200 mg with breakfast meal and 200mg with dinner meal\]) to titrate individual doses to further enhance efficacy and safety. * To examine the blood pressure (BP) effects of Marius's oral testosterone undecanoate formulation, SOV2012-F1, using 24-hour ambulatory blood pressure monitoring (ABPM).

Study identification

NCT ID
NCT04467697
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Marius Pharmaceuticals
Industry
Enrollment
155 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 18, 2018 (Actual)
Primary completion
May 1, 2020 (Actual)
Completion
May 1, 2020 (Actual)
Last update posted
Jun 28, 2024

2018 – 2020

United States locations

U.S. sites
19
U.S. states
12
U.S. cities
19
Facility City State ZIP Site status
Alabama Clinical Therapeutics, LLC Birmingham Alabama 35235 —
Coastal Clinic Research Inc Mobile Alabama 36608 —
South Florida Medical Research Aventura Florida 33180 —
PAB Clinical Research Brandon Florida 33511 —
Jacksonville Impotence Treatment Center Jacksonville Florida 32223 —
My Community Research Center Miami Florida 33155 —
Oviedo Medical Research, LLC Oviedo Florida 32765 —
Meridien Research St. Petersburg Florida 33709 —
Northwest Clinical Trials Boise Idaho 83704 —
Centex Studies, Inc. Lake Charles Louisiana 70601 —
Quality Clinical Research, Inc. Omaha Nebraska 68114 —
Palm Research Center, Inc. Las Vegas Nevada 89148 —
Accumed Research Associates Garden City New York 11530 —
Manhattan Medical Research Practice, PLLC New York New York 10016 —
Rapha Institute for Clinical Research Fayetteville North Carolina 28314 —
Urologic Consultant of SE Pennyslvania Bala-Cynwyd Pennsylvania 19004 —
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464 —
University Diabetes Endocrine Consultants Chattanooga Tennessee 37411 —
Centex Studies, Inc. Houston Texas 77058 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04467697, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 28, 2024 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04467697 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →